Major Depressive Disorder (MDD)

Treatment is often challenging: an estimated 20% -40% of patients do not benefits sufficiently from existing antidepressant intervention including trials of medication and psychotherapy (Greden 2001)

16.1 million US adults with MDD

7.2 million treated

4.5 million poorly served